We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
EARLY CTDNA CLEARANCE AFTER CAR T‐CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B‐CELL LYMPHOMA : RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY.
- Authors
Delfau‐Larue, M.; Viailly, P.; Cartron, G.; Morschhauser, F.; Gros, F.; Gastinne, T.; Oberic, L.; Bachy, E.; Dulery, R.; Feugier, P.; Menard, C.; Quelen, C.; Pangault, C.; Portugues, C.; Gomes, L.; Itti, E.; Bailly, C.; Lemonnier, F.; Laurent, C.; Houot, R.
- Abstract
EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY B Introduction: b CAR T-cells have significantly improved the outcome of patients with relapsed or refractory ( I R i / I R i ) large B-cell lymphoma (LBCL). The aim of our study was to monitor ctDNA before and after CAR T-cell infusion and correlate the results with clinical outcome in the ALYCANTE trial.
- Subjects
CIRCULATING tumor DNA; T cells; LYMPHOMAS
- Publication
Hematological Oncology, 2023, Vol 41, p179
- ISSN
0278-0232
- Publication type
Article
- DOI
10.1002/hon.3163_113